Lenovo Announces New Innovations in Gaming, Software, Visuals, and Accessories for the Holidays
Today, Lenovo announced several new products and solutions at its annual holiday product launch. The new additions to the portfolio – which include AI-tuned innovations in gaming, a groundbreaking 3D monitor, software solutions, versatile accessories, and more – are available to explore here.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230831307965/en/
Lenovo Announces New Innovations in Gaming, Software, Visuals, and Accessories for the Holidays (Photo: Business Wire)
Gaming on the Go: Lenovo Legion™ Gaming Handheld Device and Accessories Untether PC Gaming
The new Lenovo Legion Go is the company’s first Windows gaming handheld device that gives gamers more freedom to game however—and wherever—they want. The Lenovo Legion Go is designed for gamers who will settle for nothing less than top-tier specs and visuals on their handheld device. Along with the new micro-OLED-equipped Lenovo Legion Glasses and new Lenovo Legion E510 7.1 RGB Gaming In-Ear Headphones, the debut of the Lenovo Legion Go is a marked expansion of the Lenovo Legion ecosystem of gaming devices, monitors, accessories, software, and services that empower gamers to immerse themselves in their games.
- The new Lenovo Legion Go brings Windows PC gaming power to a handheld mobile form factor, powered by AMD Ryzen™ Z1 Series processors that bring games to life on its 8.8-inch Lenovo PureSight Gaming Display.
- For gamers who want to take their Lenovo Legion Go portable gaming experience to the next level, the new Lenovo Legion Glasses leverage micro-OLED technology to provide a large screen viewing experience that fits in the pocket.
- For a truly immersive gaming experience, the new Lenovo Legion E510 7.1 RGB Gaming In-Ear Headphones offer hi-res 7.1 surround sound audio with a multifunction inline controller.
The King of Cool: Lenovo Legion 9i is the World’s First AI-Tuned Gaming Laptop with an Integrated Liquid-Cooling System1
The Lenovo Legion 9i (16”, 8) is the first top-of-the-line 16-inch gaming laptop in Lenovo Legion’s ecosystem—and in the world—with a self-contained liquid-cooling system1, designed for gamers and creators with heavy graphic workflow requirements who need a full development studio in their bag. The Lenovo Legion 9i leads the Lenovo Legion lineup that also includes the Lenovo Legion Pro series for competitive gamers and the Lenovo Legion Slim series for gamers who value agility, as well as Lenovo Legion displays and peripherals. Also announced today are the Lenovo Legion 16” Gaming Backpack GB700 and GB400, two backpack options that give gamers a choice between slim and lightweight agility or extra storage without sacrificing protection for their Lenovo Legion 9i (16”, 8) or any other laptops and accessories.
Transforming Digital Workspaces: New Devices and Software Power the Future of Hybrid Work
In addition to new gaming devices, Lenovo is unveiling new cutting-edge tech tools and essentials tailored to empower the dynamic, evolving needs of today's business end-users. Its new monitor, software, and accessories are not only designed to boost the capabilities of today’s remote and hybrid workforces, but also to address significant challenges faced by businesses as they digitize operations across departments. Lenovo research shows that managing a remote workforce and global teams remain central tasks for CIOs.2 That’s why the new offerings integrate impressive processing power, immersive 3D, and advanced security to create a unified, human-centered experience.
- For professional content creators who require immersive 3D visualization, the new ThinkVision™ 27 3D Monitor – a stunning 27-inch, glasses-free, 2D/3D compatible monitor – offers seamless 3D effects and real-time eye-tracking.
- The new Lenovo Wired VOIP Headset and Lenovo Wired ANC Headset Gen 2 are high-quality audio solutions for professionals in hybrid work environments, include an inline call control box, active noise cancellation with the latter, and compatibility with popular conferencing platforms.
- For remote work and to support sustainability efforts, the cloud-based Lenovo Device Manager will roll out enhanced new features that include a comprehensive AI-powered energy management solution that efficiently manages device fleets and optimizes power usage.
- To round out the new line-up are a selection of sophisticated and comfortable carry cases, the Lenovo ThinkPad Professional 16inch Backpack Gen 2, and the ThinkPad Professional 16inch and 14inch Topload Gen 2.
For specific details on all the new products and solutions, see the various releases linked below and the press kit on Lenovo StoryHub.
- The King of Cool: Lenovo Introduces the Legion 9i, the World’s First AI-Tuned Gaming Laptop with Integrated Liquid-Cooling System
- Gaming on the Go: Lenovo Unveils a New Legion Gaming Handheld Device and Accessories that Untether PC Gaming
- Transforming Digital Workspaces: Lenovo Unveils New Devices and Software to Power the Future of Hybrid Work
About Lenovo
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$62 billion revenue global technology powerhouse, ranked #217 in the Fortune Global 500, employing 77,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s largest PC company by further expanding into growth areas that fuel the advancement of ‘New IT’ technologies (client, edge, cloud, network, and intelligence) including server, storage, mobile, software, solutions, and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and smarter future for everyone, everywhere. To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.
1Per an internal research conducted as of June 22, 2023, based on comparisons of gaming computers distributed by global PC manufacturers shipping > 1 million units worldwide annually, contained in a 16" panel size supported with a liquid cooling pump and does not have an external cooling attachment.
2 The Resilient CIO: Lenovo Global Study of CIOs 2023
LENOVO, LENOVO LEGION, and THINKVISION are trademarks of Lenovo. AMD and Ryzen are trademarks of Advanced Micro Devices. Inc. All other trademarks are the property of their respective owners. ©2023 Lenovo Group Limited
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230831307965/en/
Contact information
Wendy Fung, wfung@lenovo.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Receives CHMP Positive Opinion for ALYFTREK ® , a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis28.4.2025 09:03:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Our goal has always been to serially innovate to help people with cystic fibrosis live healthier and longer lives. If approved, this new medicine would be indicated for people with CF ages 6 years and older with at least one non-class I mutation, meaning more patients would be eligible for a medicine that gets them closer to normal levels of sweat chloride,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. “CFTR modulators have already revolutionized the way we treat CF and I am encoura
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets28.4.2025 08:02:00 EEST | Press release
Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 receptor (S1R) agonist designed to regulate key neuroprotective mechanisms often impaired in neurodegenerative diseases such as HD and ALS. Under the terms of the agreement, Prilenia will receive an upfront payment of approximately €80 million plus up to €45 million in near-term development, regulatory, and commercial milestones. The total deal is valued at up to approximately €500 million in upfront and total milestone payments. In addition, Prilenia will receive tiered double-digit royalties on
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine28.4.2025 08:00:00 EEST | Press release
Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V.,a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement in which Ferrer obtains the rights to develop, manufacture and commercialize Pridopidine in the European Region, the Middle East and North African Region, the Southern African Region, the Central and South American Region, and the Commonwealth of Independent States Region. Pridopidine, a potent and highly selective, orally administered sigma-1 receptor agonist, designed to regulate key neuroprotective mechanisms that are often impaired in neurodegenerative diseases, is a promising candidate for the treatment of Huntington’s Disease (HD), a rare inherited neurodegenerative disease, with a high unmet medical need1. It has been studied in more than 1,700 people and long-term safety data of up to 7 years duration are available from previou
Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease27.4.2025 12:36:00 EEST | Press release
Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformative therapies for WD patients. About FDA Designations The Rare Pediatric Disease Designation (RPDD) incentivizes therapies for serious or life-threatening diseases affecting fewer than 200,000 U.S. patients, primarily those aged 18 or younger. Sponsors may qualify for a Priority Review Voucher (PRV) upon approval to expedite FDA review of a subsequent drug application. The Orphan Drug Designation (ODD) supports therapies targeting rare diseases (affecting fewer than 200,000 U.S. patients) by provi
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 20:00:00 EEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom